Smaller incisions, big hopes: new surgery for stomach cancer under trial
NCT ID NCT05076279
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a newer, less invasive type of stomach cancer surgery (using just one or a few small cuts) is as safe and effective as the standard approach. The trial involves 108 people with advanced stomach cancer who need their stomach partially removed. The main goal is to see if the surgery can remove enough lymph nodes while causing fewer side effects and improving recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
single or reduced ports laparoscopic gastrectomy (surgical procedure)
What this could lead to
If successful, this could offer a less invasive surgical option for advanced gastric cancer, potentially leading to faster recovery and fewer complications.
What could go wrong
This is a small, early-phase trial with only 108 participants, so results may not apply to all patients. The surgery is complex and carries standard surgical risks like infection or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea